Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study

Jeffrey D. Bradley; Shunichi Sugawara; Ki Hyeong Lee; Gyula Ostoros; Ahmet DEMİRKAZIK; Milada Zemanová; Virote Sriuranpong; Ana Caroline Zimmer Gelatti; Juliana Janoski De Menezes; Bogdan A. Żurawski; Michael Newton; Pratibha Chander; Nan Jia; Zofia Felicja Bielecka; Mustafa Özgüroğlu; on behalf of the PACIFIC-2 Investigators

doi:10.1200/jco-25-03012

Erratum: Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study

Journal of Clinical Oncology 2026

View at publisher

Authors: Jeffrey D. Bradley, Shunichi Sugawara, Ki Hyeong Lee, Gyula Ostoros, Ahmet DEMİRKAZIK, Milada Zemanová, Virote Sriuranpong, Ana Caroline Zimmer Gelatti, Juliana Janoski De Menezes, Bogdan A. Żurawski, Michael Newton, Pratibha Chander

+4 more

Nan Jia, Zofia Felicja Bielecka, Mustafa Özgüroğlu, on behalf of the PACIFIC-2 Investigators

DOI: 10.1200/jco-25-03012

Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies

Publication details

Journal / source: Journal of Clinical Oncology
Volume: 44
Issue: 5
Pages: 429–429
Publication date: 7 January 2026
Language: EN